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Abstract
Disruption of epigenetic patterns is a major change occurring in all types of cancers. Such
alterations are characterized by global DNA hypomethylation, gene-promoter hypermethy-
lation and aberrant histone modifications, and may be modified by environment. Nutritional
factors, and especially dietary lipids, have a role in the etiology of breast cancer. Thus, we
aimed to analyze the influence of different high fat diets on DNA methylation and histone
modifications in the rat dimethylbenz(a)anthracene (DMBA)-induced breast cancer model.
Female Sprague-Dawley rats were fed a low-fat, a high corn-oil or a high extra-virgin olive
oil (EVOO) diet from weaning or from induction with DMBA. In mammary glands and tumors
we analyzed global and gene specific (RASSF1A, TIMP3) DNAmethylation by LUMA and
bisulfite pyrosequencing assays, respectively. We also determined gene expression and
enzymatic activity of DNA methyltransferases (DNMT1, DNMT3a and DNMT3b) and evalu-
ated changes in histone modifications (H3K4me2, H3K27me3, H4K20me3 and H4K16ac)
by western-blot. Our results showed variations along time in the global DNA methylation of
the mammary gland displaying decreases at puberty and with aging. The olive oil-enriched
diet, on the one hand, increased the levels of global DNA methylation in mammary gland
and tumor, and on the other, changed histone modifications patterns. The corn oil-enriched
diet increased DNA methyltransferase activity in both tissues, resulting in an increase in the
promoter methylation of the tumor suppressor genes RASSF1A and TIMP3. These results
suggest a differential effect of the high fat diets on epigenetic patterns with a relevant role in
the neoplastic transformation, which could be one of the mechanisms of their differential
promoter effect, clearly stimulating for the high corn-oil diet and with a weaker influence for
the high EVOO diet, on breast cancer progression.
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Introduction
Breast cancer is the most frequent malignant neoplasia among women worldwide [1]. In addi-
tion to genetic, epigenetic and endocrine factors, the environment, and specifically nutritional
factors, plays a key role in its etiology. Epidemiological evidence and research studies in animal
models suggest that diet, and mainly dietary lipids, play an important role in breast cancer
development [2]. Thus, n-6 polyunsaturated fatty acids (PUFA) from vegetable oils, especially
linoleic acid (18:2n-6) and saturated fat, mainly from animal origin, have shown a stimulating
effect on breast cancer. In contrast, an inhibitory effect has been described for n-3 PUFA, con-
jugated linoleic acid and γ-linolenic acid. Monounsaturated fatty acids (MUFA), mainly oleic
acid (18:1n-9, OA), present in high quantities in olive oil, seems to be protective, although
some inconsistent data have been reported ranging from protective to weak stimulating effects
on tumor growth [3, 4]. In this sense, abundant results have attributed a protective effect on
breast cancer risk to Mediterranean Diet, characterized by the consumption of olive oil as the
main source of energy [5]. The specific mechanisms by which EVOO (Extra Virgin Olive Oil)
and other dietary lipids may exert their modulatory effects on cancer are not fully understood.
Several nutrients with anticancer potential have shown to influence epigenome by interfering
with processes deregulated during carcinogenesis, such as global DNA hypomethylation, tumor
suppressor gene promoter hypermethylation and aberrant histone modifications [6]. Global
DNA hypomethylation reflects loss of methylation associated with aberrant expression of some
genes that could contribute to neoplastic transformation, tumorigenesis, cancer progression and
chromosomal instability [7]. On the other hand, methylation-dependent gene silencing is a nor-
mal mechanism for regulation of gene expression [8]. In cancer cells, gene promoter hypermethy-
lation represents a mutation-independent mechanism for inactivation of tumor suppressor genes.
A significant number of cancer-related genes are subject to methylation-dependent silencing, and
many of these genes contribute to the hallmarks of cancer, such as RASSF1A (Ras-association
domain family 1, isoform A) and TIMP3 (Tissue inhibitor of metalloproteinase-3) [9]. DNA
methylation is catalyzed by the enzyme 5-cytosine DNAmethyltransferase (DNMT) commonly
classified as maintenance (DNMT1) and de novo (DNMT3a andDNMT3b). The levels of
DNMT, especially those ofDNMT3a andDNMT3b, are often increased in various cancer tissues
and cell lines. This may partially account for the hypermethylation of promoter CpG-rich regions
of tumor suppressor genes in a variety of malignancies [10]. In addition to DNAmethylation dis-
ruption, aberrant histone modifications play a role in the carcinogenesis process. Post-transla-
tional modifications of histone determine DNA-histone interaction and transcriptional activity of
genome, having a functional cross-talk with DNAmethylation. Among the various modifications,
acetylation and methylation of histone lysines such as H4K16ac, H4K20me3, H3K27me3 and
H3K4me2, have been frequently associated with breast cancer [11–13].
Given the increasingly evidence that dietary factors can influence epigenetic changes, a bet-
ter knowledge of the interrelationships among dietary lipids, epigenetic modifications and
breast cancer is necessary to determine the utility of interventions with nutritional components
for breast cancer prevention. Hence, the aim of the present study is to analyze the influence of
different high fat diets, rich in corn oil or in EVOO, on DNA methylation and histone modifi-
cations in the rat dimethylbenz(a)anthracene-induced breast cancer model.
Materials and Methods
Animals and experimental design
All animals received humane care under an institutionally approved experimental animal
protocol, following the legislation applicable in this country. The protocol, which included
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euthanasia by decapitation, was approved by the Ethical Committee of Animal and Human
Experimentation of our institution (CEEAH 566/3616). Female Sprague-Dawley rats were
obtained from Charles River Lab. (L’Arbresle, France, N = 167) and housed 2–3 per cage in a
controlled environment and 12:12h light/dark cycle. The day after arrival (23 days of age), 6
animals were euthanized by decapitation and the remaining rats distributed upon the type of
diet and timing of dietary intervention (S1 Fig). Three semi-synthetic diets were designed: a
low fat diet (3% corn oil-w/w-), a high corn oil diet (20% corn oil) and a high olive oil diet (3%
corn oil + 17% extra virgin olive oil). The composition, preparation and suitability of the exper-
imental diets have been described previously [14–16]. Thus, from weaning onwards, control
animals were fed the low fat diet (Group LF, N = 87), while the high fat groups animals were
fed the high corn oil diet (Group HCO, N = 37) or the high extra virgin olive oil diet (Group
HOO, N = 37) and water ad libitum. At 53 days of age, mammary cancer was induced by oral
gavage with one single dose of 5 mg of dimethylbenz(a)anthracene (DMBA) (Sigma-Aldrich;
St. Louis, MO, USA) dissolved in corn oil. To study the promotion of the carcinogenesis, after
DMBA treatment 50 rats from the LF group were changed to high fat dietary intervention, thus
forming the Group low fat—high corn oil (LF-HCO, N = 25), and the Group low fat—high
extra virgin olive oil (LF-HOO, N = 25). Animals were euthanized at day 36 (N = 6 / experi-
mental condition: control, HCO, HOO), 51 (N = 6 / experimental condition: control, HCO,
HOO), 100 (N = 6 / group) and 236–256 (median 246 days, end of the assay), (N = 20 / group).
Abdominal mammary glands were collected and flash frozen for molecular analyses. At the
end of the assay tumors were excised, a portion fixed in 4% formalin for histopathological diag-
nosis [17], and the rest flash frozen for molecular analyses. Only data from confirmed mam-
mary adenocarcinomas has been included in this study.
DNA isolation and bisulfite modification
Genomic DNA was extracted from mammary glands and tumors using the SpeedTools Tissue
DNA Extraction kit (Biotools B&M Labs, Madrid, Spain), according to the manufacturer's rec-
ommendations. The concentration of extracted DNAs was determined using the NanoDrop
ND-1000 spectrophotometer (Thermo Fisher Scientific). The 260/280 and 260/230 nm ratios
were used to evaluate the DNA purity and the integrity was assessed by 1% agarose gel electro-
phoresis and ethidium bromide staining.
The extracted DNAs were treated with sodium bisulfite using the CpGenome™ Turbo Bisul-
fite Modification Kit (Merck Millipore, Billerica, MA, USA), converting all unmethylated cyto-
sine to uracil.
Determination of global DNA methylation level (LUminometric
Methylation Assay-LUMA-)
Global DNAmethylation level was determined by LUMA as described previously [18] with
modifications [19]. Briefly, genomic DNA was cleaved with HpaII + EcoRI-HF orMspI +
EcoRI-HF (New England Biolabs) in two parallel reactions containing 500 ng genomic DNA
and 5U of each restriction enzyme. The reactions were incubated for 4 hours at 37°C. Samples
were analyzed in the Centre for Research in Agricultural Genomics (CRAG) from the Universi-
tat Autònoma de Barcelona, using the PyroMark Q96 ID System (Qiagen), with the following
dispensation order: GTGTCACATGTGTG. Percentage of DNA methylation was expressed as
[1 –(HpaII+EcoRI SG/ST/(MspI+EcoRI SG/ST)]100. This percentage represents the amount
of 5-mC within the CCGG motif throughout the genome.
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RNA isolation and gene expression analysis by Real-Time PCR
Total RNA from mammary glands and tumors were extracted using the Tissue RNeasy
Extraction Kit (Qiagen, Hilden, Germany). RNA was quantified spectrophotometrically with
NanoDrop ND-1000 spectrophotometer (Thermo Fisher Scientific, Waltham, MA, USA),
and integrity was assessed by 2% agarose gel electrophoresis and ethidium bromide staining.
Two micrograms of total RNA were reverse transcribed using the High Capacity cDNA
Reverse Transcription Kit (Applied Biosystems, Foster City, CA, USA). The study of expres-
sion of specific genes was performed by real-time PCR using the TaqMan methodology
(Applied Biosystems), in the iCycler MyiQ Real-Time PCR detection system (Bio-Rad Labo-
ratories, Hercules, CA, USA). Reactions were prepared with the TaqMan Universal PCR
Master Mix and the suitable TaqMan assay: Rn01445298_m1 (RASSF1A), Rn00441826_m1
(TIMP3), Rn00709664_m1 (DNMT1), Rn01469994_g1 (DNMT3A) and Rn01536419_m1
(DNMT3B). Twenty nanograms of cDNA were amplified during 40 cycles of 15 seconds at 95°C
and 60 seconds at 60°C. Gene expression was normalized usingHPRT1 (Rn01527840_m1) as a
control transcript.
Quantitative methylation analysis (pyrosequencing)
Bisulfite pyrosequencing was used to determine the promoter methylation of RASSF1A and
TIMP3 genes in bisulfite-modified DNAs, from mammary glands and tumors. Predesigned
methylation assays were used to determine the methylation status of three and six CpG sites in
the RASSF1A (PM00416297) and TIMP3 (PM00574896) promoter respectively (PyroMark
CpG assay, Qiagen). Briefly, 1 μl of bisulfite-modified DNA (25 ng) was amplified using 1U
Platinum1 Taq High Fidelity (Thermo Fisher Scientific) in a 25 μl final volume. The amplifica-
tion conditions were: denaturating at 95°C for 5 minutes, followed by 45 cycles at 95°C for 30
seconds, at 55°C for 30 seconds, at 72°C for 45 seconds and a final extension at 72°C for 5 min-
utes. Simple robust amplification was confirmed by visualization in 2% agarose gel stained
with ethidium bromide. Pyrosequencing reactions were then analyzed in the Centre for
Research in Agricultural Genomics (CRAG) from the Universitat Autònoma de Barcelona,
using in the PSQ HS 96 Pyrosequencing Instrument. Methylation data were presented as the
percentage of average methylation in all observed CpG sites.
DNMT activity
Global DNAmethyltransferase (DNMT) activity was evaluated in nuclear protein extracts
from mammary glands and tumors obtained using the EpiQuik Nuclear Extraction Kit (Epi-
gentek, Farmingdale, NY, USA). DNAmethyltransferase activity was measured in duplicates
using the EpiQuik™ DNMTActivity/Inhibition Assay Ultra Kit (Epigentek), following manu-
facturer’s recommendations. Replicates of each sample (include blank and positive control)
were analyzed to validate the signal generated. The DNMT activity data were presented as OD/
h/mg.
Histone modifications
Modifications of histone 4 (H4K20me3, H4K16ac) and histone 3 (H3K4me2, H3K27me3)
were determined in nuclear protein extracts from mammary glands and tumors. Samples were
resolved by SDS-PAGE in Any kD™Mini-PROTEAN1 TGX Stain-Free™ Gels (Bio-Rad Labo-
ratories) for 30 minutes at 200 volts, and transferred to PVDF membranes with Trans-Blot1
Turbo™ Transfer System (Bio-Rad Laboratories). Primary antibodies used were Anti-Histone
H4 (tri methyl K20) (1:5000), Anti-Histone H4 (acetyl K16) (1:5000), Anti-Histone H4
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(1:5000), Anti-Histone H3 (di methyl K4) (1:1000), Anti-Histone H3 (1:10000) from Abcam
(Cambrigde, UK) and Anti-Histone H3 (tri methyl K27) (1:1000) from Epigentek (Farming-
dale, NY, USA). Horseradish peroxidase conjugated rabbit secondary antibody was obtained
from Sigma–Aldrich (St. Louis, MO, USA). Immunoreactive proteins were visualized using
the Luminata™ Forte Western HRP Substrate (Merck Millipore). Densitometric values of
bands were analyzed and normalized to the protein loaded on each sample using the Chemi-
Doc XRS+ system and the Image Lab™ software (Bio-Rad Laboratories). Values were related
to an internal control pool loaded in duplicate in each gel, and normalized to global histone 3
or histone 4.
Statistical analysis
Statistical analyses were performed using SPSS software (20.0 Version) and R/Deducer soft-
ware (3.1.2 Version). The distribution of each variable was determined by the Kolmogoroz–
Smirnov test and the equality of variances among groups was determined by Leven’s test.
Quantitative data were analyzed by the nonparametric Mann–Whitney’s U-test. The level of
significance was established at P<0.05.
Results
Effects of high fat diets and breast cancer on global DNA methylation
Results of global DNA methylation in mammary gland displayed variations along time, show-
ing clear decreases at puberty (from 23 to 36 days) and in adulthood (from 100 to 246 days)
(Fig 1b). In relation to the effect of diets, the group fed with the olive oil one (HOO) showed
the highest methylation levels at all ages, close to significance compared to HCO at 36 days and
compared to LF at 51 days of age (Fig 1b). In mammary tumors, both groups fed the olive oil-
enriched diet had higher values of global DNA methylation (significantly in HOO and close to
significance in LF-HOO) compared to LF group (Fig 1c). Finally, we compared the global
DNAmethylation between mammary gland and tumor in each experimental group at 246
days of age, finding no clear differences among tissues, except an increase in tumor compared
to mammary gland in both groups fed the olive oil-enriched diet (significantly in LF-HOO and
close to significance in HOO) (Fig 1d).
Effects of high fat diets and breast cancer on RASSF1A and TIMP3
mRNA relative levels
Results for RASSF1A and TIMP3 gene expression in mammary gland showed a great variability
along time, displaying different trends in adolescence (36 and 51 days) and in adulthood (100
and 246 days of age). The RASSF1A gene expression showed a maximum at 100 days in all
groups (except HCO) and a decrease thereafter (Fig 2a). The TIMP3 gene expression decreased
along time in all high fat groups, while reached its maximum at 100 days of age in LF group
(Fig 2b). The high fat diets did not modify RASSF1A expression at the ages tested. TIMP3
expression decreased in LF-HCO group compared to LF group at the end of the assay (246
days) (Fig 2b). In tumors, RASSF1A gene expression showed a significant decrease in both high
olive oil groups in relation to LF and high corn oil groups (Fig 2c), while TIMP3 expression
was lower in LF-HOO group compared with the LF control (Fig 2d). Comparison between tis-
sues showed a significant decrease in the expression of both genes in tumors in all experimental
groups (Fig 2e and 2f).
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Effects of high fat diets and breast cancer on DNA promoter methylation
of RASSF1A and TIMP3 genes
The promoter methylation of RASSF1A (Fig 3a) and TIMP3 (Fig 3b) genes were determined in
bisulfite-modified DNAs from mammary glands and tumors at 246 days. In mammary gland,
both groups fed the corn oil-enriched diet had significant increased values of RASSF1Amethyl-
ation compared to LF group. Values from HCO were also significantly higher than those from
HOO (Fig 3c). TIMP3mehtylation was also increased in HCO group compared to LF and high
extra virgin olive oil groups (Fig 3d). In tumors, the methylation levels of RASSF1A increased
in all high fat diet groups except in LF-HCO (Fig 3e). TIMP3 promoter methylation tended to
increase in HCO group versus the control, whilst the LF-HOO group had significantly lower
levels compared with all other high fat groups (Fig 3f). Finally, comparison between tissues
showed an increase in both RASSF1A and TIMP3 promoter methylation in tumors, compared
to mammary glands, in all the experimental groups. (Fig 3g and 3h).
Effects of high fat diets and breast cancer on DNMT1, DNMT3a and
DNMT3b mRNA relative levels
The mRNA relative levels of the maintenance DNA methyltransferase (DNMT1) and the
de novomethyltransferases (DNMT3a and DNMT3b) were analyzed by real time PCR in
Fig 1. Global DNAmethylation level in mammary gland and tumor. (a)Representative pyrograms obtained in LUMA assay of DNA cleaved with HpaII
+EcoRI-HF andMspI+EcoRI-HF. (b) Determination of global DNAmethylation in mammary gland from all experimental groups along time. (c)Global DNA
methylation in tumors from all experimental groups at the end of the assay (246 days). (d) Comparison of global DNAmethylation between mammary gland
and tumors in each experimental group at 246 days of age. Data shown represent medians of the groups. Full lines connecting groups indicate differences
statistically significant (p<0.05); dotted lines indicate differences close to significance (p<0.1).
doi:10.1371/journal.pone.0138980.g001
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mammary gland and in tumors at the end of the assay. The DNMT1mRNA relative levels
were always higher compared to DNMT3a and DNMT3bmRNA levels in both tissues and in
all experimental groups (Fig 4). Expression levels of DNMT in mammary gland at 246 days
of age showed a significant increase in DNMT1mRNA levels in HCO (Fig 4a) and a decrease
in DNMT3bmRNA in HOO compared to LF and HCO groups (Fig 4c). In tumors, we did
not find significant differences in DNMT1 and DNMT3amRNA relative levels among
groups, although a trend to lower DNMT3a levels in EVOO groups was observed (Fig 4d and
4e). DNMT3b expression was decreased in HCO and in both high olive oil groups in compar-
ison to the control (Fig 4f). We also compared values from mammary gland and tumor in
each experimental group finding, in general, a decrease of DNMT expression in tumor,
mainly in DNMT3a and DNMT3b (Fig 4 g–4i).
Effects of high fat diets and breast cancer on DNMT activity
We determined the total (de novo and maintenance) DNA methyltransferase activity at the
end of the assay (246 days of age) in mammary gland and tumor. In both tissues, HCO group
showed an increase in DNMT activity compared with all other groups. In addition, HOO
group showed an increase in DNMT activity compared to LF-HOO group in both tissues
and compared to low fat group in mammary gland (Fig 5a and 5b). Comparison between
Fig 2. RASSF1A and TIMP3 gene expression in mammary gland and tumor.Determination of RASSF1A (a) and TIMP3 (b)mRNA relative levels in
mammary gland from all experimental groups along time. Determination of RASSF1A (c) and TIMP3 (d)mRNA relative levels in tumors from all experimental
groups at 246 days of age. Comparison of RASSF1A (e) and TIMP3 (f)mRNA relative levels between both tissues in each experimental group at 246 days of
age. Data shown represent medians of the groups. Full lines connecting groups indicate differences statistically significant (p<0.05); dotted lines indicate
differences close to significance (p<0.1).
doi:10.1371/journal.pone.0138980.g002
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mammary gland and tumor in each experimental group showed a statistical significant increase
in the tumor DNMT activity in all groups except in HCO (Fig 5c).
Effects of high fat diets and breast cancer on histone modifications
Global levels of histone 3 (H3K4me2, H3K27me3) and histone 4 (H4K20me3, H4K16ac) mod-
ifications have been determined in mammary gland and tumor at 246 days of age by western
blotting (Fig 6a). In mammary gland, we found no clear differences of such histone modifica-
tions among experimental groups, except a significant decrease of H3K27me3 relative levels in
HCO group compared to LF group, and a trend to decrease the H4K16ac relative levels in
HOO group (Fig 6b). In tumors, the high fat diets did not significantly influence the relative
levels of histone 3 modifications (H3K4me2, H3K27me3). Results of histone 4 modifications
showed a decrease of H4K20me3 relative levels in LF-HOO group compared with all other
groups, and a decrease of H4K16ac in LF-HOO compared to HOO group (Fig 6c). We also
compared the global levels of histone 3 and histone 4 modifications between mammary gland
and tumor in each experimental group at 246 days of age finding, in general, a decrease of such
modifications in tumor (Fig 6d).
Fig 3. DNA promoter methylation ofRASSF1A and TIMP3 genes in mammary gland and tumor. Representative pyrogram of RASSF1A (a) and TIMP3
(b) promoter methylation analyses. Determination of RASSF1A and TIMP3DNAmethylation in mammary gland (c, d) and tumor (e, f) from all experimental
groups at 246 days of age. Comparison of RASSF1A (g) and TIMP3 (h) gene methylation between both tissues in each experimental group at 246 days of
age. Data shown represent medians of the groups. Full lines connecting groups indicate differences statistically significant (p<0.05); dotted lines indicate
differences close to significance (p<0.1).
doi:10.1371/journal.pone.0138980.g003
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Discussion
Disruptions of epigenetic patterns including global DNA hypomethylation, tumor suppressor
gene promoter hypermethylation and aberrant histone modifications have been considered
hallmarks of cancer [20]. These epigenetic changes are reversible and may be modified by
nutritional factors, including dietary lipids. In the present study, we have investigated the
effect of diets rich in corn oil or in extra virgin olive oil on DNA methylation and histone
Fig 4. DNAmethyltransferase gene expression in mammary gland and tumor.Determination of DNMT1, DNMT3a and DNMT3bmRNA relative levels
in mammary gland (a, b and c) and tumors (d, e and f) from all experimental groups at 246 days of age. Comparison of DNMT1 (g), DNMT3a (h) and
DNMT3b (i)mRNA relative levels between both tissues in each experimental group at 246 days of age. Data shown represent medians of the groups. Full
lines connecting groups indicate differences statistically significant (p<0.05); dotted lines indicate differences close to significance (p<0.1).
doi:10.1371/journal.pone.0138980.g004
Dietary Lipids, Epigenetics and Breast Cancer
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modifications in the rat DMBA-induced breast cancer model. Our results revealed different
mechanisms of action of such diets on epigenetic patterns, which could play an important role
in the strong enhancing effect described for the high corn oil diet and the weaker effect of the
EVOO diet on breast cancer progression.
Previous results in the same animals that have been used in this work, showed a strong
tumor enhancing effect of the high corn oil diet when administered from weaning (Group
HCO) and from induction (Group LF-HCO), while a weak effect of the high olive oil diet
administered in the same periods [21, 22]. Thus, by 246 days of age the high corn oil diet
induced a significantly higher percentage of tumor-bearing animals (incidence: LF 80% -16/20-
, HCO 100% -20/20-, LF-HCO 100% -20/20-, HOO 75% -15/20-, LF-HOO 85% -17/20-) and
tumor yield (number of tumors: LF 46, HCO 99, LF-HCO 87, HOO 58, LF-HOO 83). More-
over, tumors from groups fed such diet tended to appear earlier and had higher volume, and
displayed morphological characteristics of higher malignancy. Hence, in this work we aimed to
get insight into the molecular mechanisms by which these high fat diets had their differential
effects on experimental mammary carcinogenesis.
Global DNA hypomethylation has been associated with neoplastic transformation, tumori-
genesis, cancer progression and chromosomal instability [7]. To study the effect of high fat
diets on genomic methylation, we have determined the global DNAmethylation level of mam-
mary gland and tumor in rats fed diets rich in corn oil or in EVOO. We first observed varia-
tions along time in the genomic DNA methylation of the mammary gland, displaying
decreases at puberty (from 23 to 36 days) that may be related to the mammary gland develop-
ment [23, 24]. We have also found an age-related decrease of methylation in adulthood (from
100 to 246 days). Although no data have been reported in this model, such result is in accor-
dance with published evidence in human tissues, which demonstrate that physiologic aging is
also accompanied by widespread epigenetic changes, including gradual loss of global DNA
methylation [25]. In relation to the effect of diet, our data also showed higher levels of methyla-
tion in EVOO groups, both in mammary gland at all ages and in tumor, suggesting an inhibi-
tory effect of EVOO on cancer-related global DNA hypomethylation. This result can be related
to previous experimental series where we have observed from a weak protective effect of the
high EVOO diet [16] to a weak enhancing effect after chronic intake [21, 22]. Finally, we have
Fig 5. DNAmethyltransferase activity in mammary gland and tumor.Determination of DNMT activity in mammary gland (a) and tumors (b) from all
experimental groups and comparison between both tissues (c). Data shown represent medians of the groups. Full lines connecting groups indicate
differences statistically significant (p<0.05); dotted lines indicate differences close to significance (p<0.1).
doi:10.1371/journal.pone.0138980.g005
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also compared the levels of genomic methylation among mammary gland and tumor in each
experimental group at 246 days of age. Contrary to our expectations [20], levels in tumor were
not lower than in mammary gland. This could be related to the fact that this gland has suffered
a carcinogenic insult. Although no data has been found in DMBA-induced mammary gland, in
ACI rats exposure to estrogen and ionizing irradiation decrease global DNA methylation of
this tissue [26, 27].
It is well-known that global DNA hypomethylation and tumor suppressor hypermethyla-
tion promote carcinogenesis, affecting DNA stability and gene expression [20, 28]. To further
investigate the effects of diets, we have analyzed the expression of the tumor suppressor genes
RASSF1A and TIMP3, which have important roles on the key hallmarks that a neoplastic cell
acquires, and are frequently down-regulated in breast cancer [29, 30]. We have determined the
mRNA relative levels of both genes in mammary gland at all ages and in tumor. We have
observed changes in mammary gland along lifetime, with RASSF1A and TIMP3mRNA levels
increasing during the adolescence (36 and 51 days). This regulation may be related to the
Fig 6. Global levels of histone 3 (H3K4me2, H3K27me3) and histone 4 (H4K20me3, H4K16ac) modifications in mammary gland and tumor.
Representative images obtained for western blot data frommammary gland and tumor of histone 3 and histone 4 modifications (a). Determination of relative
levels of such modifications in mammary gland (b) and tumor (c) from all experimental groups at 246 days of age. Comparison of global levels of histone
modifications between both tissues (d) in each experimental group. Data shown represent medians of the groups. Full lines connecting groups indicate
differences statistically significant (p<0.05); dotted lines indicate differences close to significance (p<0.1).
doi:10.1371/journal.pone.0138980.g006
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proliferation and differentiation associated with the mammary gland development, and is in
concordance with the reported increase in tumor suppressor expression at the end of puberty
in such gland [31]. We also found a decrease in the RASSF1A and TIMP3 gene expression in
the adulthood along time (100 and 246 days of age), in accordance with promoter methylation
and transcriptional silencing of tumor suppressor genes with aging [32]. In relation to the
effects of the high fat diets, little influence was observed in mammary gland, whilst in tumor
the EVOO groups showed lower levels of RASSF1A and TIMP3mRNA. As expected, compari-
son between tissues indicated a down-regulation in tumor versus mammary gland in all experi-
mental groups, suggesting an inactivation of these tumor suppressor genes in cancer [33].
Hypermethylation of CpG islands in the promoter regions of tumor suppressor genes is one
of the main mechanisms for gene silencing [34]. Thus, we have analyzed the promoter methyl-
ation of RASSF1A and TIMP3 genes in mammary gland and tumor at 246 days of age, finding
a significant increase in both tissues in the corn oil-enriched diet groups, especially in HCO.
On the other hand, the EVOO diet, despite being also high fat, only increased RASSF1A pro-
moter methylation in the tumor, suggesting a selective mechanism of action on promoter
methylation of such diet. In this sense, hydroxytyrosol and oleuropein, the most representative
poliphenols in extra virgin olive oil, are able to selectively regulate Type 1 cannabinoid receptor
(CB1) expression, a tumor suppressor gene, in Caco-2 cells and in the rat colon via epigenetic
mechanisms [35]. In our study, the comparison between tissues showed an increase of
RASSF1A and TIMP3methylation in tumor in all experimental groups. It is in concordance
with the hypermethylation of tumor suppressor genes described in cancer [29, 30].
DNA methylation is catalyzed by the enzyme 5-cytosine DNAmethyltransferase (DNMT).
There are three main DNMT enzymes that possess catalytic methyltransferase activity:
DNMT1 (maintenance methyltransferase), DNMT3a and DNMT3b (de novomethyltrans-
ferases). Hence, we investigated the effects of the high fat diets on DNMT function, determin-
ing mRNA levels of DNMT1, DNMT3a and DNMT3b, as well as DNMT activity in mammary
gland and tumor at 246 days of age. We found higher DNMT1mRNA levels compared to de
novo DNMT in both tissues and in all experimental groups, according to the literature [10],
and a coordinated expression of DNMT1, DNMT3a and DNMT3b in mammary gland and
tumor, as it has been described in several tissues [36]. In relation to the effect of dietary lipids,
in mammary gland we observed an increase in DNMT1 expression in HCO and a decrease in
DNMT3b expression in HOO group. In tumor, DNMT3bmRNA was decreased in all high fat
groups. Surprisingly, a decrease of DNMT expression in tumor, compared to mammary gland
was, also detected, mainly in DNMT3a and DNMT3b. Thus, we analyzed DNMT activity find-
ing that, as expected [37], it was increased in tumors versus mammary gland. This imbalance
between mRNA levels and DNMT activity indicates that DNMT function is relevantly regu-
lated on the post-transcriptional level. Furthermore, when we analyzed the DNMT activity in
relation to the diet administered, an increase in HCO group was found in both tissues (mam-
mary gland and tumor). A consequence of this increase in HCO group could be the higher val-
ues of DNA promoter methylation of RASSF1A and TIMP3 genes detected in both tissues [38,
39], which could be one of the mechanisms of the stimulating effect of carcinogenesis of such
diet [3, 4, 16, 24, 40, 41]. On the other hand, the olive oil-enriched diets showed intermediate
values between the obtained in the low fat group and the corn oil-enriched diet groups, maybe
due to the action of poliphenols of EVOO which have shown DNMT inhibition properties
[42–44]. Finally, in both tissues there was an increase in DNMT activity in HCO and HOO
groups compared with their counterparts LF-HCO and LF-HOO, suggesting that time and
duration of high fat diet implementation could have an effect on DNMT activity in such tis-
sues, promoting the carcinogenesis process.
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DNA methylation and histone modifications interact with each other in the regulation of
gene expression [20]. Therefore, we analyzed the effects of the high fat diets on global levels
of histone 3 (H3K4me2, H3K27me3) and histone 4 (H4K20me3, H4K16ac) modifications,
in mammary gland and tumor at 246 days of age. As far as we know, no data has been pub-
lished in rat DMBA-induced breast cancer model about dietary effects on these histone mod-
ifications. Results showed a decrease in mammary gland of H3K27me3 relative levels in
HCO group, and a decrease in tumor of H4K20me3 relative levels in LF-HOO group com-
pared with all other groups. These results could be considered a mechanism by which these
lipids influence rat carcinogenesis [3, 4]. Finally, we also compared the global levels of his-
tone 3 and histone 4 modifications between mammary gland and tumor, finding, in general,
higher levels of such modifications in mammary gland tissue, according to published data
[11–13].
In conclusion, the corn oil-enriched diet increased DNMT activity both in mammary gland
and tumor, more likely as a consequence of the stimulation of activity than of the increase in
mRNA levels. This effect was reflected in the promoter methylation of RASSF1A and TIMP3
genes in both tissues. However, methylation changes of these genes did not reflect the varia-
tions observed in the mRNA levels, indicating the relevant role of other mechanisms regulating
their transcriptional silencing. In any case, increases in DNMT activity are related to gene-spe-
cific methylation, suggesting that the corn oil-enriched diet may induce hypermethylation of
several genes, whose silencing would have a role on the carcinogenesis-promoting effect of this
diet [9]. RASSF1A and TIMP3 are tumor suppressor genes that could be inactivated though
epigenetic mechanisms in early-events of the carcinogenesis process and, therefore, in the
long-term their expression may not reflect the degree of malignancy of tumors. Respect the
olive oil-enriched diet, on the one hand, decreased the levels of global DNA hypomethylation
and, on the other, changed histone modification patterns. We have previously demonstrated a
strong enhancing effect of high corn oil diet on mammary carcinogenesis, while the EVOO
diet, despite being high fat, had a weaker effect. Considering the unspecific promoter influence
that all high fat diets have on experimental carcinogenesis [45], the EVOOmust have some
beneficial effects that may partially counteract the total fat intake. Its richness in MUFA and
other bioactive components such as phenolic compounds, squalene could be the responsible of
the weak protective effect detected in our study. Altogether, our results suggest different effects
of the high fat diets, rich in corn oil or in olive oil, on epigenetic mechanisms with a relevant
role in the neoplastic transformation. This specific influence could be at the basis, at least in
part, of the differential promoter effects described by PUFA n-6 enriched oils and EVOO on
breast cancer progression.
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